Brief: Stoke Therapeutics - As Of Sept. 30 $214.7 Million In Cash, Cash Equivalents & Marketable Securities, To Fund Operations To End Of 2025
07/11/2023 12:14
Nov 7 (Reuters) - Stoke Therapeutics Inc STOK.O :
* STOKE THERAPEUTICS INC - AS OF SEPT 30, HAD $214.7 MILLION
IN
CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES, TO FUND
OPERATIONS TO END OF 2025
Source text for Eikon: ID:nBw2XMLxna
Further company coverage: STOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics